Insightec

Company Overview

Snapshot

Founded in March 1999 by Kobi Vortman, Insightec operates with 201–500 employees. The company has raised a total of $592.9 million across nine funding rounds from 18 investors. In June 2024, Insightec announced a financing round with Fidelity Management &.

Business overview

Insightec is a global healthcare company that develops and commercializes MR-guided focused ultrasound systems. Its core technology, the Exablate Neuro platform, uses focused sound waves guided by MRI to provide incisionless treatment for patients with medication-refractory Essential Tremor and Parkinson's Disease. The company serves the medical and healthcare industries, focusing on applications ranging from functional neurosurgery to oncology and gynecology, operating within the Health Tech & Life Sciences sector.

Strategic signal

In September 2024, Insightec announced a strategic collaboration with Charles River Laboratories to advance therapeutic development utilizing focused ultrasound in neuroscience. This partnership highlights Insightec's commitment to expanding the applications of its core technology and signals a strategic move towards broader therapeutic development, potentially opening new market opportunities and validating its platform's versatility for investors.

Company Intelligence Q&A

What was a significant recent strategic partnership for Insightec?

In September 2024, Insightec announced a strategic collaboration with Charles River Laboratories International to advance therapeutic development using focused ultrasound in neuroscience.

What was a key leadership appointment at Insightec in 2024?

In September 2024, Insightec appointed Jake Ghannam as its Chief Commercial Officer, a move aimed at strengthening its commercial strategy and market presence.

What was a notable financing event for Insightec in 2024?

In June 2024, Insightec announced a financing round of $150 million to fund continued growth, with Fidelity Management &.

What regulatory approval did Insightec receive in September 2023?

In September 2023, Insightec received CE Mark approval to treat Essential Tremor patients' second side, expanding treatment options for individuals living with the condition.

What new CPT code did Insightec announce in November 2023?

In November 2023, Insightec announced a new Category I CPT code from the AMA for neuro procedures utilizing MR-guided focused ultrasound, which can facilitate broader reimbursement for its treatments.